36th Congress of the European Society of Clinical Microbiology & Infectious Diseases

Make sure to visit us at booth B60 Hall B1 where we have invited expert speakers from around the world to share and discuss their experiences in infectious disease management.

For more information about our in-booth talks and sessions at ESCMID 2026, signup to get access to our dedicated event webpage, to explore the agenda and save the sessions most relevant to you directly to your calendar.

Roche Symposium

Roche in-booth talks

Innovation and Pipeline Theater

Diagnosing infections accurately and rapidly is a constant challenge in clinical microbiology. While advanced diagnostics offer powerful new tools, ensuring they are timely, accessible, and effectively integrated into clinical practice is crucial for intervention. How can we best leverage these innovations to improve patient care?

In this session, experts will explore forward-thinking strategies and practical innovations in the field. Attendees will learn about the future of clinical microbiology, the implementation of molecular diagnostic systems for critical tests, and new approaches to TB biomarker discovery that move beyond traditional methods.

Agenda:
Bridging the gap in microbiology: realizing advances in diagnostics and access  across the globe
Katharina Kranzer, PhD
Health Research Unit Zimbabwe & London School of Hygiene and Tropical Medicine
 

From Molecular Detection to Clinical Decision: Integrating microbiology BCID testing and templated reporting comments for guided treatment of bloodstream infections
Mateu Espasa, MD
Hospital Clínic de Barcelona
 

Novel non-sputum-based biomarkers for TB diagnosis: Finding the missing millions
Michael Hoelscher, MD
LMU Munich

Chair: Nina Germic, PhD, Medical Affairs Lead, Roche Diagnostics Solutions, Rotkreuz

This talk will explore the current landscape of flexible syndromic testing using large molecular panels, highlighting the impact of this feature to clinical laboratories as well as patient care. It will focus on how labs might approach flexible testing for GI, covering design considerations, necessary data sets and operationalization.  Finally, an overview of the cobas® eplex Flexible Syndromic Testing feature on the cobas® eplex gastrointestinal panel will be provided. 

Erin McElvania, PhD, D(ABMM) Endeavor Health, IL, USA
Organiser: Pedro L. Rodriguez, PhD, Roche Molecular Systems | GenMark

This talk will highlight the current diagnostics landscape for Dengue, including the perceived  challenges and how automation can revolutionize this space. We will also highlight the Roche products in this space along with the respective automated workflows.

Carolin Bier, PhD, Roche Molecular Systems | Core Lab

The effective management of tuberculosis infection increasingly requires robust, reliable, scalable, and easy-to-use diagnostic tools capable of handling high-volume and random access demands. This talk will characterize the new Elecsys IGRA TB assay, focusing on its integration into automated clinical laboratory environments. We will highlight the impact on workflow efficiency and analytical performance improvements, including data on precision and reproducibility. Finally, preliminary clinical data will be presented, and we will discuss the assay's utility as a diagnostic tool for TB infection, supporting global elimination goals.

Markus Eckl & Qian Feng, Roche Diagnostics Solutions, Rotkreuz, CH
Organiser: Nina Germic, PhD, Roche Molecular Systems | Core Lab